Shingles vaccine cuts dementia risk, study finds
Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia


What happened
Getting vaccinated against shingles appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia, according to a study published Wednesday in the journal Nature. The study, based on the health records of 280,000 people in Wales, found that those who received an older live-virus vaccine, Zostavax, were 20% less likely to develop dementia within seven years than those not vaccinated.
Who said what
Previous research suggested that "shingles vaccinations might reduce dementia risk," including a 2024 study that found even greater protection from the newer vaccine Shingrix, The New York Times said. But the latest study overcame limitations in earlier observational data by taking advantage of a "natural experiment" in Wales, where health officials allowed 79-year-olds to get vaccinated but not 80-year-olds, effectively creating a randomized trial among two groups born weeks apart.
A 20% dementia reduction from the shingles vaccine would be "quite important," especially as "we don’t really have much else at the moment that slows down the onset of dementia," Oxford researcher Dr. Paul Harrison, who wasn't involved in this study, told the Times. People should get vaccinated regardless, Dr. Aarati Didwania of Northwestern University said to NBC News. "Shingles is a terrible, painful and debilitating condition that can lead to horrendous long-term pain."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Further research is needed to understand why viruses like shingles and other members of the herpes family appear to boost dementia odds, why the shingles vaccine offers protection and the efficacy of Shingrix.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
The Y chromosome degrades over time. And men's health is paying for it
Under the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young people
Under the radar Most exposure occurs in childhood
-
RFK Jr.'s focus on autism draws the ire of researchers
In the Spotlight Many of Kennedy's assertions have been condemned by experts and advocates
-
Protein obsession is oversaturating the health food space
Under the Radar Some experts say that fiber is now the most important macro to focus on
-
Strep infections are rising in the US
Under the radar The cases have more than doubled in 10 years
-
Hantavirus: the rare pathogen linked to rodents that attacks the lungs
The Explainer Despite the low risk of contracting it, the virus could be potentially deadly
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about